Preservatives in multidose formulations of topical ophthalmic medications are crucial for
maintaining sterility but can be toxic to the ocular surface. Benzalkonium chloride (BAK) …

Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to
reduce intraocular pressure remains the mainstay treatment. These eye drops frequently …

Glaucoma is one of the leading causes of irreversible blindness. Progression is halted with a
reduction in intraocular pressure (IOP), which is most often achieved with eye drops. A major …

Ocular surface disease (OSD), a disorder affecting the lacrimal and meibomian glands and
the corneal and conjunctival epithelium, is a well-known complication of topical glaucoma …

Dry eye disease (DED) has been found to occur at a higher prevalence in individuals with
glaucoma than in individuals without glaucoma. The relationship between glaucoma and …

Patients with glaucoma greatly benefit from combining cataract surgery with a MIGS
procedure that can be tailored to disease severity and medication use. Certain MIGS …

Ophthalmic formulations have enormous applications in treating several ocular disorders.
Principally, the ocular formulations must be sterile. Hence, preservatives are conventionally …

Purpose To report the role of prostaglandin-associated periorbitopathy (PAP) severity in the
surgical effectiveness of trabeculectomy (LEC). Design Retrospective observational case …

Background Long-term use of topical, especially benzalkonium chloride (BAC)-preserved,
antiglaucoma medications can cause a negative impact on the ocular surface. The aim of …

Purpose To investigate the effect of polyquaternium‐1 (PQ)‐preserved and benzalkonium
chloride (BAK)‐preserved travoprost eye drops on viability of primary human conjunctival …